PCSK9 Forum is made possible thanks to support from AstraZeneca, LIB Therapeutics, Novartis and Sanofi, all of whom have no influence or control of editorial content. More information is available here »

Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

20th Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 24th April 2024 (Educational supporters)

Post-ACS therapeutic strategies: What has changed?

Post-ACS therapeutic strategies: What has changed?

Reports from the 20th Virtual Closed Scientific Expert Meeting of the Editorial Board  Matthew Budoff

read more »
CRISPR engineering of wild-type alleles versus millions of years of human evolution

CRISPR engineering of wild-type alleles versus millions of years of human evolution

Reports from the 20th Virtual Closed Scientific Expert Meeting of the Editorial Board  Steven Farber

read more »
The statin intolerant patient with ASCVD: What is your therapeutic strategy?

The statin intolerant patient with ASCVD: What is your therapeutic strategy?

Reports from the 20th Virtual Closed Scientific Expert Meeting of the Editorial Board  Ioanna Gouni-Berthold

read more »
PCSK9 inhibition with a novel fusion protein

PCSK9 inhibition with a novel fusion protein

Reports from the 20th Virtual Closed Scientific Expert Meeting of the Editorial Board  Frederick Raal

read more »
Oral PCSK9 inhibition: Clinical update

Oral PCSK9 inhibition: Clinical update

Reports from the 20th Virtual Closed Scientific Expert Meeting of the Editorial Board  Christie Ballantyne

read more »